JP2013532295A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532295A5 JP2013532295A5 JP2013519748A JP2013519748A JP2013532295A5 JP 2013532295 A5 JP2013532295 A5 JP 2013532295A5 JP 2013519748 A JP2013519748 A JP 2013519748A JP 2013519748 A JP2013519748 A JP 2013519748A JP 2013532295 A5 JP2013532295 A5 JP 2013532295A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- biomarkers
- biomarker
- lung cancer
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 claims 40
- 238000000034 method Methods 0.000 claims 33
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 14
- 201000005202 lung cancer Diseases 0.000 claims 14
- 208000020816 lung neoplasm Diseases 0.000 claims 14
- 238000003556 assay Methods 0.000 claims 6
- 239000012472 biological sample Substances 0.000 claims 6
- 238000000099 in vitro assay Methods 0.000 claims 6
- 108091023037 Aptamer Proteins 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 230000002380 cytological effect Effects 0.000 claims 4
- 210000004072 lung Anatomy 0.000 claims 4
- 102100027998 Macrophage metalloelastase Human genes 0.000 claims 2
- 101710187853 Macrophage metalloelastase Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- -1 antibodies Proteins 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 230000002685 pulmonary effect Effects 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36312210P | 2010-07-09 | 2010-07-09 | |
| US61/363,122 | 2010-07-09 | ||
| US201161444947P | 2011-02-21 | 2011-02-21 | |
| US61/444,947 | 2011-02-21 | ||
| PCT/US2011/043595 WO2012006632A2 (en) | 2010-07-09 | 2011-07-11 | Lung cancer biomarkers and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532295A JP2013532295A (ja) | 2013-08-15 |
| JP2013532295A5 true JP2013532295A5 (https=) | 2014-08-28 |
| JP5905003B2 JP5905003B2 (ja) | 2016-04-20 |
Family
ID=45441874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013519748A Active JP5905003B2 (ja) | 2010-07-09 | 2011-07-11 | 肺癌バイオマーカーとその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130116150A1 (https=) |
| EP (1) | EP2591357A4 (https=) |
| JP (1) | JP5905003B2 (https=) |
| KR (1) | KR101870123B1 (https=) |
| CN (2) | CN102985819B (https=) |
| AU (1) | AU2011274422B2 (https=) |
| BR (1) | BR112012032537B8 (https=) |
| CA (1) | CA2801110C (https=) |
| IL (1) | IL223295A (https=) |
| MX (2) | MX2012014268A (https=) |
| SG (2) | SG186953A1 (https=) |
| WO (1) | WO2012006632A2 (https=) |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2021792T3 (pl) | 2006-05-09 | 2013-08-30 | Univ British Columbia | Rozpuszczone białkowe markery zapalenia stawów |
| JP5615181B2 (ja) | 2007-11-27 | 2014-10-29 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 関節炎の予防及び治療のための組成物及び方法 |
| US8285719B1 (en) | 2008-08-08 | 2012-10-09 | The Research Foundation Of State University Of New York | System and method for probabilistic relational clustering |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US20100221752A2 (en) * | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| WO2010102412A1 (en) | 2009-03-11 | 2010-09-16 | Augurex Life Sciences Corporation | Compositions and methods for characterizing arthritic conditions |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| SG186953A1 (en) | 2010-07-09 | 2013-02-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
| CN103415624B (zh) | 2010-08-13 | 2017-03-01 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| US20140235487A1 (en) * | 2010-11-12 | 2014-08-21 | William Marsh Rice University | Oral cancer risk scoring |
| PT2768851T (pt) | 2011-10-21 | 2017-09-08 | Augurex Life Sciences Corp | Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide |
| US20130282390A1 (en) * | 2012-04-20 | 2013-10-24 | International Business Machines Corporation | Combining knowledge and data driven insights for identifying risk factors in healthcare |
| WO2013163568A2 (en) * | 2012-04-26 | 2013-10-31 | Allegro Diagnostics Corp. | Methods for evaluating lung cancer status |
| JP6022285B2 (ja) * | 2012-09-28 | 2016-11-09 | シスメックス株式会社 | 標本収納装置、標本収納方法、及び標本検査システム |
| US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
| EP4170031A1 (en) | 2012-10-23 | 2023-04-26 | Caris Science, Inc. | Aptamers and uses thereof |
| WO2014074682A1 (en) | 2012-11-07 | 2014-05-15 | Somalogic, Inc. | Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
| AU2013361323B2 (en) | 2012-12-19 | 2018-09-06 | Caris Science, Inc. | Compositions and methods for aptamer screening |
| EP2968988A4 (en) | 2013-03-14 | 2016-11-16 | Allegro Diagnostics Corp | METHOD FOR EVALUATING A COPD STATUS |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| WO2014150198A2 (en) | 2013-03-15 | 2014-09-25 | Somalogic, Inc. | Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof |
| US11085083B2 (en) | 2013-03-18 | 2021-08-10 | Visible Genomics, Llc | Methods to determine carcinogenesis, identify markers for early cancer diagnosis and identify targets of therapy |
| EP3461909A1 (en) * | 2013-05-21 | 2019-04-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy |
| KR101552014B1 (ko) | 2013-10-11 | 2015-09-09 | 인제대학교 산학협력단 | 폐암 진단을 위한 nir의 신규한 용도 |
| WO2015066564A1 (en) * | 2013-10-31 | 2015-05-07 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| MX2016005825A (es) | 2013-11-07 | 2016-12-09 | Medial Res Ltd | Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon. |
| CN106415563B (zh) * | 2013-12-16 | 2020-06-05 | 菲利普莫里斯生产公司 | 用于预测个体的吸烟状况的系统和方法 |
| RU2538625C1 (ru) * | 2014-01-20 | 2015-01-10 | Денис Николаевич Бахмутов | Способ диагностики рака |
| WO2015164616A1 (en) | 2014-04-24 | 2015-10-29 | Somalogic, Inc. | Biomarkers for detection of tuberculosis |
| WO2015164617A1 (en) | 2014-04-24 | 2015-10-29 | Somalogic, Inc. | Tuberculosis biomarkers in urine and uses thereof |
| WO2015164772A1 (en) * | 2014-04-25 | 2015-10-29 | Rush University Medical Center | Circulating insulin-like growth factor (igf)-associated proteins for the detection of lung cancer |
| WO2016011068A1 (en) * | 2014-07-14 | 2016-01-21 | Allegro Diagnostics Corp. | Methods for evaluating lung cancer status |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| WO2016048388A1 (en) | 2014-09-26 | 2016-03-31 | Somalogic, Inc. | Cardiovascular risk event prediction and uses thereof |
| US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| WO2016123058A1 (en) | 2015-01-27 | 2016-08-04 | Somalogic, Inc. | Biomarkers for detection of tuberculosis risk |
| WO2016182967A1 (en) | 2015-05-08 | 2016-11-17 | Somalogic, Inc. | Biomarkers for detection of tuberculosis risk |
| CN107923918A (zh) * | 2015-09-09 | 2018-04-17 | 私募蛋白质体公司 | 用于开发个性化药物治疗计划和基于蛋白质组谱的靶向药物开发的方法 |
| KR102087373B1 (ko) * | 2015-09-11 | 2020-03-10 | 주식회사 압타머사이언스 | 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법 |
| US10546650B2 (en) | 2015-10-23 | 2020-01-28 | Google Llc | Neural network for processing aptamer data |
| US20210215711A1 (en) | 2016-02-08 | 2021-07-15 | Somalogic, Inc. | Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof |
| JP6041331B1 (ja) * | 2016-02-26 | 2016-12-07 | 国立大学法人山口大学 | 情報処理装置と情報処理プログラム並びに情報処理方法 |
| JP6889428B2 (ja) * | 2016-02-26 | 2021-06-18 | 国立大学法人山口大学 | 情報処理装置と情報処理プログラム並びに情報処理方法 |
| CN107435062B (zh) * | 2016-05-25 | 2020-10-20 | 上海伯豪医学检验所有限公司 | 甄别肺部微小结节良恶性的外周血基因标志物及其用途 |
| CA3026650A1 (en) * | 2016-06-08 | 2017-12-14 | Research Development Foundation | Systems and methods for automated coronary plaque characterization and risk assessment using intravascular optical coherence tomography |
| WO2017223216A1 (en) * | 2016-06-21 | 2017-12-28 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| JP7311417B2 (ja) | 2017-02-09 | 2023-07-19 | ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム | 肺癌の検出および処置のための方法 |
| JP2020522690A (ja) * | 2017-06-02 | 2020-07-30 | ベラサイト インコーポレイテッド | 肺疾病の特定又はモニタリング方法及びシステム |
| CN109470855B (zh) * | 2017-09-08 | 2022-02-11 | 广州市丹蓝生物科技有限公司 | 肺癌早期诊断用蛋白芯片及试剂盒 |
| CA3085464A1 (en) | 2017-12-19 | 2019-06-27 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| KR102028967B1 (ko) | 2017-12-28 | 2019-10-07 | 한국원자력의학원 | Ｒｉｐ1을 포함하는 폐암 전이 진단용 바이오 마커 및 이의 이용 |
| WO2019202448A1 (en) | 2018-04-16 | 2019-10-24 | University Of Cape Town | A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis |
| EP3810563A4 (en) * | 2018-06-22 | 2022-03-23 | Somalogic, Inc. | IMPROVED PROTEOMIC MULTIPLEX TESTS |
| WO2020018005A1 (en) * | 2018-07-17 | 2020-01-23 | Limited Liability Company "Gero" | Devices, methods, compositions and systems for the treatment of aging and age- related disorders |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| KR102216645B1 (ko) * | 2018-10-29 | 2021-02-17 | 사회복지법인 삼성생명공익재단 | 폐암의 분자 아형 결정을 위한 바이오마커 패널 및 이의 용도 |
| CA3116768A1 (en) * | 2018-10-30 | 2020-05-07 | Somalogic, Inc. | Methods for sample quality assessment |
| CN109470859A (zh) * | 2018-11-04 | 2019-03-15 | 华东医院 | 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用 |
| WO2020132520A2 (en) * | 2018-12-20 | 2020-06-25 | Veracyte, Inc. | Methods and systems for detecting genetic fusions to identify a lung disorder |
| EP3671210A1 (en) * | 2018-12-21 | 2020-06-24 | Biosystems International KFT | Lung cancer protein epitomic biomarkers |
| WO2020243574A1 (en) * | 2019-05-31 | 2020-12-03 | Delphinus Medical Technologies, Inc. | Systems and methods for interactive lesion characterization |
| US20210027890A1 (en) * | 2019-07-24 | 2021-01-28 | ConnSante BioTech, Inc. | Detecting, evaluating and predicting system for cancer risk |
| JP7712913B2 (ja) | 2019-09-03 | 2025-07-24 | ソマロジック オペレーティング カンパニー インコーポレイテッド | 心血管リスク／イベントの予測及びその使用 |
| CN115023615A (zh) | 2020-01-10 | 2022-09-06 | 私募蛋白质体操作有限公司 | 确定葡萄糖耐量减低的方法 |
| AU2021213150A1 (en) | 2020-01-30 | 2022-08-04 | Prognomiq Inc | Lung biomarkers and methods of use thereof |
| KR20220140727A (ko) | 2020-02-10 | 2022-10-18 | 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 | 비알코올성 지방간염 (nash) 바이오마커 및 이의 용도 |
| KR102260915B1 (ko) | 2020-02-19 | 2021-06-04 | 한국원자력의학원 | 폐암의 방사선 치료 예후 예측을 위한 생체 표지자 |
| CN111876478B (zh) * | 2020-04-28 | 2025-11-21 | 中国科学院微生物研究所 | 肺结节诊断标志物及应用 |
| US20230304099A1 (en) * | 2020-08-14 | 2023-09-28 | The Medical College Of Wisconsin, Inc. | Gene Expression Signature for Predicting Immunotherapy Response and Methods of Use |
| EP4222287A4 (en) * | 2020-10-02 | 2024-12-18 | Board of Regents, The University of Texas System | METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER |
| CN116381073A (zh) * | 2020-10-10 | 2023-07-04 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 生物标志物在制备肺癌检测试剂中的用途和方法 |
| ES3041461T3 (en) | 2020-10-20 | 2025-11-12 | Somalogic Operating Co Inc | Cardiovascular event risk prediction |
| WO2022212583A1 (en) | 2021-03-31 | 2022-10-06 | PrognomIQ, Inc. | Multi-omic assessment |
| GB2607436A (en) * | 2021-03-31 | 2022-12-07 | Prognomiq Inc | Multi-omic assessment |
| EP4700792A3 (en) * | 2021-03-31 | 2026-04-29 | Prognomiq Inc | Multi-omic assessment |
| WO2023039479A1 (en) | 2021-09-10 | 2023-03-16 | PrognomIQ, Inc. | Direct classification of raw biomolecule measurement data |
| CN118215845A (zh) | 2021-09-13 | 2024-06-18 | 普罗科技有限公司 | 增强的对生物分子的检测和定量 |
| MX2024008874A (es) | 2022-01-21 | 2024-07-29 | Somalogic Operating Co Inc | Metodos de evaluacion de calidad de muestras. |
| JP2025516096A (ja) | 2022-04-24 | 2025-05-27 | ソマロジック オペレーティング カンパニー インコーポレイテッド | 試料品質評価の方法 |
| CA3246311A1 (en) | 2022-04-24 | 2023-11-02 | Somalogic Operating Co., Inc. | METHODS FOR EVALUATING THE QUALITY OF A SAMPLE |
| US20250052766A1 (en) | 2022-04-24 | 2025-02-13 | Somalogic Operating Co., Inc. | Methods for Sample Quality Assessment |
| EP4515246A1 (en) | 2022-04-24 | 2025-03-05 | SomaLogic Operating Co., Inc. | Methods for sample quality assessment |
| WO2023244582A1 (en) * | 2022-06-13 | 2023-12-21 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Lung cancer-related biomarkers and methods of using the same |
| WO2024010854A1 (en) * | 2022-07-07 | 2024-01-11 | Diagnose Early, Inc. | Rapid generation of breath-based health reports and systems for use in the same |
| CA3259129A1 (en) | 2022-07-14 | 2024-01-18 | Somalogic Operating Co., Inc. | Methods of assessing dementia risk |
| WO2024015486A1 (en) | 2022-07-14 | 2024-01-18 | Somalogic Operating Co., Inc. | Methods for sample quality assessment |
| EP4591066A2 (en) | 2022-09-23 | 2025-07-30 | SomaLogic Operating Co., Inc. | Methods of assessing tobacco use status |
| WO2024130196A2 (en) * | 2022-12-16 | 2024-06-20 | Droplet Biosciences, Inc. | Analysis of effluent |
| CN116539894A (zh) * | 2023-05-08 | 2023-08-04 | 复旦大学附属中山医院 | Capg在制备病理性心肌肥厚检测试剂中的应用 |
| WO2025010324A1 (en) | 2023-07-06 | 2025-01-09 | Somalogic Operating Co., Inc. | Detection of target molecules in dried biologic matrices |
| WO2026072744A2 (en) | 2024-09-26 | 2026-04-02 | Somalogic Operating Co., Inc. | Methods of assessing hypertrophic cardiomyopathy |
| CN120559238A (zh) * | 2025-05-27 | 2025-08-29 | 中国人民解放军总医院第一医学中心 | 蛋白质标志物在制备用于肺磨玻璃结节良恶性鉴别的产品中的应用 |
Family Cites Families (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US20040254101A1 (en) | 1995-06-06 | 2004-12-16 | Human Genome Sciences, Inc. | Colon specific gene and protein and cancer |
| AU6688598A (en) | 1997-03-07 | 1998-09-22 | University Of Florida | Method for diagnosing and staging prostate cancer |
| WO2000052204A2 (en) | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
| DE60039441D1 (de) | 1999-09-10 | 2008-08-21 | Takashi Muramatsu | Tumormarker für frühes krebsstadium |
| EP1472352A4 (en) | 2000-03-06 | 2005-10-12 | Smithkline Beecham Corp | NEW COMPOUNDS |
| US20030224501A1 (en) | 2000-03-17 | 2003-12-04 | Young Paul E. | Bone morphogenic protein polynucleotides, polypeptides, and antibodies |
| US6596503B1 (en) | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| US6631330B1 (en) | 2000-08-21 | 2003-10-07 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers |
| US6576423B2 (en) | 2000-12-08 | 2003-06-10 | The Board Of Regents Of The University Of Nebraska | Specific mucin expression as a marker for pancreatic cancer |
| AU2002309583A1 (en) * | 2001-04-18 | 2002-11-05 | Protein Desing Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| US7189507B2 (en) | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| US20040009489A1 (en) | 2001-09-28 | 2004-01-15 | Golub Todd R. | Classification of lung carcinomas using gene expression analysis |
| US20040241653A1 (en) * | 2001-12-31 | 2004-12-02 | Elena Feinstein | Methods for identifying marker genes for cancer |
| ES2374311T3 (es) | 2002-03-13 | 2012-02-15 | Genomic Health, Inc. | Obtención de perfil de expresión génica en tejidos tumorales biopsiados. |
| JP4679149B2 (ja) | 2002-09-30 | 2011-04-27 | オンコセラピー・サイエンス株式会社 | ヒト膵癌に関連する遺伝子およびポリペプチド |
| US20050260639A1 (en) | 2002-09-30 | 2005-11-24 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
| WO2004046386A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| WO2004055519A2 (en) | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Specific markers for pancreatic cancer |
| AU2003294377A1 (en) | 2002-12-18 | 2004-07-29 | Ciphergen Biosystems, Inc. | Serum biomarkers in lung cancer |
| WO2004063355A2 (en) | 2003-01-10 | 2004-07-29 | Protein Design Labs, Inc. | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| WO2004074518A1 (en) | 2003-02-20 | 2004-09-02 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
| CA2516591A1 (en) | 2003-02-26 | 2004-09-10 | Mount Sinai Hospital | Multiple marker assay for detection of ovarian cancer |
| US20050095611A1 (en) | 2003-05-02 | 2005-05-05 | Chan Daniel W. | Identification of biomarkers for detecting pancreatic cancer |
| CN1455257A (zh) * | 2003-05-23 | 2003-11-12 | 北京师范大学 | 一种利用表面修饰蛋白芯片进行肺癌诊断方法 |
| US20060019256A1 (en) | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| HUE050365T2 (hu) | 2003-06-24 | 2022-09-28 | Genomic Health Inc | Rákkiújulás valószínûségének elõrejelzése |
| AU2004258085B2 (en) | 2003-07-10 | 2010-05-27 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| AU2004264948A1 (en) | 2003-08-15 | 2005-02-24 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Multifactorial assay for cancer detection |
| US7807392B1 (en) | 2003-09-15 | 2010-10-05 | Celera Corporation | Lung disease targets and uses thereof |
| WO2005043163A2 (en) | 2003-11-04 | 2005-05-12 | Roche Diagnostics Gmbh | Method for distinguishing who classified aml subtypes |
| JP4912894B2 (ja) | 2004-02-19 | 2012-04-11 | イェール ユニバーシティー | プロテオーム技術を使用した癌タンパク質バイオマーカーの同定 |
| JP2007527247A (ja) | 2004-03-05 | 2007-09-27 | ロゼッタ インファーマティクス エルエルシー | 臨床的基準および情報提供性遺伝子セットの組合せを使用する乳癌患者の分類 |
| ES2636470T3 (es) | 2004-04-09 | 2017-10-05 | Genomic Health, Inc. | Marcadores de expresión génica para predecir la respuesta a la quimioterapia |
| ES2367311T3 (es) | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
| AU2005236075A1 (en) | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| US20070275422A1 (en) | 2004-07-26 | 2007-11-29 | The Board Of Trustees Of The Leland Stanford Jr. U | Methods and Compositions for Detecting Pancreatic Disease |
| KR20070043868A (ko) | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | 암에 대한 혈소판 바이오마커 |
| DE602005024021D1 (de) | 2004-08-10 | 2010-11-18 | Oncotherapy Science Inc | GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoA |
| JP2006053113A (ja) * | 2004-08-16 | 2006-02-23 | Medical Proteoscope Co Ltd | 肺腺癌リンパ節転移診断方法及び診断キット |
| CA2585571C (en) | 2004-11-05 | 2020-01-21 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| JP4939425B2 (ja) | 2004-11-05 | 2012-05-23 | ジェノミック ヘルス， インコーポレイテッド | 乳癌の治療反応の予後および予測の分子指標 |
| US7862995B2 (en) | 2004-12-10 | 2011-01-04 | Targeted Molecular Diagnostics | Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor |
| US8632983B2 (en) | 2005-04-15 | 2014-01-21 | Van Andel Research Institute | Biomarkers for pancreatic cancer and diagnostic methods |
| US20070099209A1 (en) | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20090005268A1 (en) | 2005-07-18 | 2009-01-01 | Epigenomics Ag | Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers |
| US7521195B1 (en) | 2005-07-21 | 2009-04-21 | Celera Corporation | Lung disease targets and uses thereof |
| EP2295570A1 (en) | 2005-07-27 | 2011-03-16 | Oncotherapy Science, Inc. | Method of diagnosing small cell lung cancer |
| WO2007015947A2 (en) | 2005-07-29 | 2007-02-08 | Bayer Healthcare Llc | Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies |
| US7582441B1 (en) | 2005-10-17 | 2009-09-01 | Celera Corporation | Methods and compositions for treating and diagnosing disease |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
| US20090197285A1 (en) * | 2005-11-10 | 2009-08-06 | University Of Kentucky | Lung Cancer Diagnostic Assay |
| US8445198B2 (en) | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| US20070178504A1 (en) | 2005-12-22 | 2007-08-02 | Tracey Colpitts | Methods and marker combinations for screening for predisposition to lung cancer |
| NZ593226A (en) | 2006-01-11 | 2012-10-26 | Genomic Health Inc | Gene expression markers (efnb2) for colorectal cancer prognosis |
| MX2008009592A (es) | 2006-01-27 | 2008-09-08 | Tripath Imaging Inc | Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario. |
| US20080171319A1 (en) | 2006-02-06 | 2008-07-17 | Mickey Urdea | Osteoporosis associated markers and methods of use thereof |
| WO2007109571A2 (en) | 2006-03-17 | 2007-09-27 | Prometheus Laboratories, Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| US7888019B2 (en) | 2006-03-31 | 2011-02-15 | Genomic Health, Inc. | Genes involved estrogen metabolism |
| JP5308328B2 (ja) | 2006-04-04 | 2013-10-09 | シングレックス，インコーポレイテッド | トロポニンの分析のための高感度のシステムおよび方法 |
| US20080057590A1 (en) | 2006-06-07 | 2008-03-06 | Mickey Urdea | Markers associated with arteriovascular events and methods of use thereof |
| US20080090258A1 (en) | 2006-06-28 | 2008-04-17 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| EP2090665A2 (en) | 2006-10-20 | 2009-08-19 | Exiqon A/S | Novel human microRNAs associated with cancer |
| EP2087140A2 (en) | 2006-11-13 | 2009-08-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| US7964356B2 (en) | 2007-01-16 | 2011-06-21 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| KR100846354B1 (ko) * | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| WO2008117067A2 (en) | 2007-03-27 | 2008-10-02 | Carl Arne Krister Borrebaeck | Protein signature/markers for the detection of adenocarcinoma |
| RU2376372C2 (ru) | 2007-04-03 | 2009-12-20 | Государственное учреждение Научно-исследовательский институт медицинской генетики Томского научного центра Сибирского отделения Российской академии медицинских наук | Способ генетической диагностики подверженности к сердечно-сосудистым заболеваниям |
| EP2515116A1 (en) * | 2007-05-18 | 2012-10-24 | Duke University | Serum biomarkers for the early detection of lung cancer |
| US20100183514A1 (en) | 2007-05-29 | 2010-07-22 | President And Fellows Of Harvard College | Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof |
| CN101802225B (zh) * | 2007-07-17 | 2013-10-30 | 私募蛋白质体公司 | 检测样品的多元分析 |
| EP2019318A1 (en) | 2007-07-27 | 2009-01-28 | Erasmus University Medical Center Rotterdam | Protein markers for cardiovascular events |
| GB0717637D0 (en) | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
| US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| US8541183B2 (en) * | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| US20100267041A1 (en) | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
| EP2201363A4 (en) * | 2007-09-18 | 2011-03-16 | Univ Texas | DETECTION OF SPOKEN PROTEINS WITH SECONDARY MODULATION TO DUCTAL CARCINOMA IN SITU OF CHEST |
| EP3115469B1 (en) | 2007-11-19 | 2020-04-29 | Celera Corporation | Lung cancer markers and uses thereof |
| WO2009091581A2 (en) | 2008-01-18 | 2009-07-23 | Vatrix Medical, Inc. | Diagnostic biomarkers for vascular aneurysm |
| GB0803192D0 (en) | 2008-02-22 | 2008-04-02 | Mubio Products Bv | SCLC biomarker panel |
| US8067178B2 (en) | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN104198709A (zh) | 2008-09-09 | 2014-12-10 | 私募蛋白质体公司 | 肺癌生物标记及其用途 |
| US20120143805A1 (en) | 2008-09-09 | 2012-06-07 | Somalogic, Inc. | Cancer Biomarkers and Uses Thereof |
| US20120165217A1 (en) | 2008-10-06 | 2012-06-28 | Somalogic, Inc. | Cancer Biomarkers and Uses Thereof |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| US20110294683A1 (en) | 2008-10-30 | 2011-12-01 | Centre de Recherche Public de la Sant'e | Biomarkers |
| GB2512153B (en) | 2008-11-17 | 2014-11-12 | Veracyte Inc | Methods and compositions of molecular profiling for disease diagnostics |
| US10262103B2 (en) | 2008-11-18 | 2019-04-16 | Raphael LEHRER | Individualized cancer treatment |
| CN102308212A (zh) | 2008-12-04 | 2012-01-04 | 加利福尼亚大学董事会 | 用于确定前列腺癌诊断和预后的材料和方法 |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| ES2623633T3 (es) | 2009-06-09 | 2017-07-11 | Gendiag.Exe, S.L. | Marcadores de riesgo para enfermedad cardiovascular |
| AU2010260152A1 (en) | 2009-06-15 | 2012-02-02 | Cardiodx, Inc. | Determination of coronary artery disease risk. |
| EP2467719A4 (en) | 2009-08-19 | 2013-01-09 | MARKER RECOGNITION FOR CHARACTERIZING THE RISK OF CARDIOVASCULAR DISORDERS OR RESULTS COMPLICATED THEREOF | |
| US20120178111A1 (en) * | 2009-09-23 | 2012-07-12 | Diamandis Eleftherios P | Methods and compositions for the detection of lung cancers |
| WO2011050328A2 (en) | 2009-10-22 | 2011-04-28 | The Regents Of The University Of California | Assessment of solid tumor burden |
| EP2494364A1 (en) | 2009-10-29 | 2012-09-05 | Tethys Bioscience, Inc. | Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
| WO2011068839A1 (en) | 2009-12-01 | 2011-06-09 | Compendia Bioscience, Inc. | Classification of cancers |
| AU2010328019A1 (en) | 2009-12-09 | 2012-06-28 | Aviir, Inc. | Biomarker assay for diagnosis and classification of cardiovascular disease |
| US9404926B2 (en) | 2010-01-29 | 2016-08-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Immune gene signatures in cancer |
| WO2011100472A1 (en) | 2010-02-10 | 2011-08-18 | The Regents Of The University Of California | Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
| EP2542696B1 (en) | 2010-03-01 | 2016-09-28 | Caris Life Sciences Switzerland Holdings GmbH | Biomarkers for theranostics |
| JP2013526852A (ja) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
| US20110256545A1 (en) * | 2010-04-14 | 2011-10-20 | Nancy Lan Guo | mRNA expression-based prognostic gene signature for non-small cell lung cancer |
| SG186953A1 (en) | 2010-07-09 | 2013-02-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
| CN103415624B (zh) | 2010-08-13 | 2017-03-01 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| CN103429753A (zh) | 2010-09-27 | 2013-12-04 | 私募蛋白质体公司 | 间皮瘤生物标记及其用途 |
| AU2012249288C1 (en) * | 2011-04-29 | 2017-12-21 | Lung Cancer Proteomics Llc | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| ES2777002T3 (es) | 2011-09-30 | 2020-08-03 | Somalogic Inc | Predicción de eventos de riesgo cardiovascular y usos de la misma |
| NZ621733A (en) | 2011-10-24 | 2015-05-29 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
| WO2014074682A1 (en) | 2012-11-07 | 2014-05-15 | Somalogic, Inc. | Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
| KR102290214B1 (ko) | 2013-11-21 | 2021-08-18 | 소마로직, 인크. | 시티딘-5-카르복스아미드 변형된 뉴클레오티드 조성물 및 그와 관련된 방법들 |
-
2011
- 2011-07-11 SG SG2013001003A patent/SG186953A1/en unknown
- 2011-07-11 KR KR1020137000580A patent/KR101870123B1/ko active Active
- 2011-07-11 US US13/808,751 patent/US20130116150A1/en not_active Abandoned
- 2011-07-11 CN CN201180033907.2A patent/CN102985819B/zh active Active
- 2011-07-11 SG SG10201508656VA patent/SG10201508656VA/en unknown
- 2011-07-11 MX MX2012014268A patent/MX2012014268A/es not_active Application Discontinuation
- 2011-07-11 WO PCT/US2011/043595 patent/WO2012006632A2/en not_active Ceased
- 2011-07-11 MX MX2015017251A patent/MX355020B/es unknown
- 2011-07-11 EP EP11804482.5A patent/EP2591357A4/en not_active Withdrawn
- 2011-07-11 BR BR112012032537A patent/BR112012032537B8/pt active IP Right Grant
- 2011-07-11 CA CA2801110A patent/CA2801110C/en active Active
- 2011-07-11 AU AU2011274422A patent/AU2011274422B2/en active Active
- 2011-07-11 CN CN201510123032.5A patent/CN104777313B/zh active Active
- 2011-07-11 JP JP2013519748A patent/JP5905003B2/ja active Active
- 2011-10-24 US US13/279,990 patent/US20120101002A1/en not_active Abandoned
-
2012
- 2012-11-27 IL IL223295A patent/IL223295A/en active IP Right Grant
-
2018
- 2018-05-30 US US15/993,132 patent/US11221340B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532295A5 (https=) | ||
| JP2012502281A5 (https=) | ||
| JP6917432B2 (ja) | 心血管系リスクイベントの予測およびその使用 | |
| Lobo et al. | Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data | |
| ES2986657T3 (es) | Biomarcadores de la enfermedad de hígado graso no alcohólico (EHGNA) y de la esteatohepatitis no alcohólica (EHNA) y usos de los mismos | |
| Van De Voorde et al. | DNA methylation-based biomarkers in serum of patients with breast cancer | |
| KR101870123B1 (ko) | 폐암 바이오마커 및 그것의 용도 | |
| KR101658347B1 (ko) | 폐암 바이오마커 및 그것들의 용도 | |
| KR101921945B1 (ko) | 폐암 바이오마커 및 그것의 용도 | |
| Fu et al. | Liquid biopsy technologies for hematological diseases | |
| JP2017530356A5 (https=) | ||
| Meng et al. | Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19 | |
| JP2015514227A5 (https=) | ||
| JP2013513387A5 (https=) | ||
| JP7680950B2 (ja) | 生存分析によるクラス不均衡セットのダウンサンプリングを組み合わせた疾患リスクを判定するための方法 | |
| US9103837B2 (en) | Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof | |
| JP2014531046A (ja) | 疾病バイオマーカーの同定及び試料品質の評価のための好ましい試料操作及び加工プロトコルの選択 | |
| JP2014528576A5 (https=) | ||
| EP2362942A1 (en) | Biomarkers | |
| CN120188046A (zh) | 鉴定胰腺癌的方法 | |
| KR20180036787A (ko) | 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법 | |
| CN110205378A (zh) | 一组脊柱结核血浆miRNA联合诊断标记物及其应用 | |
| Nassar et al. | The role of ctDNA and liquid biopsy in the diagnosis and monitoring of head and neck cancer: towards precision medicine | |
| Qi et al. | Complex age-and cancer-related changes in human blood transcriptome—implications for pan-cancer diagnostics | |
| Elamin et al. | A specific blood signature reveals higher levels of S100A12: a potential bladder cancer diagnostic biomarker along with urinary engrailed-2 protein detection |